AR had been demonstrated to reduce cancer stemness by repression of CD44 and SOX2 [30], on the contrary, loss of AR expression could upregulate STAT3 expression and lead to promote development of cancer stemness in prostate cancer cells [31]. Here, CD44 is linked to prostate carcinoma.